Provided by Tiger Trade Technology Pte. Ltd.

Inhibikase Therapeutics, Inc.

2.39
+0.07503.25%
Volume:206.86K
Turnover:484.23K
Market Cap:333.90M
PE:-5.51
High:2.40
Open:2.30
Low:2.27
Close:2.31
52wk High:2.54
52wk Low:1.33
Shares:140.00M
Float Shares:64.52M
Volume Ratio:1.29
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4327
EPS(LYR):-0.4909
ROE:-51.96%
ROA:-32.79%
PB:2.18
PE(LYR):-4.86

Loading ...

Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Correspondence

Form CORRESP - Correspondence
Jun 18, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 10, 2024

Major Issues Report

Form 8-K - Current report
May 20, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 30, 2024

Major Issues Report

Form 8-K - Current report
Apr 30, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 25, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 19, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 19, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 27, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Major Issues Report

Form 8-K - Current report
Jan 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]